1. Home
  2. BDTX vs IGI Comparison

BDTX vs IGI Comparison

Compare BDTX & IGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BDTX
  • IGI
  • Stock Information
  • Founded
  • BDTX 2014
  • IGI 2009
  • Country
  • BDTX United States
  • IGI United States
  • Employees
  • BDTX N/A
  • IGI N/A
  • Industry
  • BDTX Biotechnology: Biological Products (No Diagnostic Substances)
  • IGI Investment Managers
  • Sector
  • BDTX Health Care
  • IGI Finance
  • Exchange
  • BDTX Nasdaq
  • IGI Nasdaq
  • Market Cap
  • BDTX 96.9M
  • IGI 99.2M
  • IPO Year
  • BDTX 2020
  • IGI N/A
  • Fundamental
  • Price
  • BDTX $1.61
  • IGI $16.55
  • Analyst Decision
  • BDTX Strong Buy
  • IGI
  • Analyst Count
  • BDTX 5
  • IGI 0
  • Target Price
  • BDTX $15.60
  • IGI N/A
  • AVG Volume (30 Days)
  • BDTX 8.2M
  • IGI 33.9K
  • Earning Date
  • BDTX 03-06-2025
  • IGI 01-01-0001
  • Dividend Yield
  • BDTX N/A
  • IGI 4.79%
  • EPS Growth
  • BDTX N/A
  • IGI N/A
  • EPS
  • BDTX N/A
  • IGI N/A
  • Revenue
  • BDTX N/A
  • IGI N/A
  • Revenue This Year
  • BDTX N/A
  • IGI N/A
  • Revenue Next Year
  • BDTX N/A
  • IGI N/A
  • P/E Ratio
  • BDTX N/A
  • IGI N/A
  • Revenue Growth
  • BDTX N/A
  • IGI N/A
  • 52 Week Low
  • BDTX $1.55
  • IGI $15.13
  • 52 Week High
  • BDTX $7.66
  • IGI $17.79
  • Technical
  • Relative Strength Index (RSI)
  • BDTX 38.60
  • IGI 46.92
  • Support Level
  • BDTX $1.55
  • IGI $16.48
  • Resistance Level
  • BDTX $1.84
  • IGI $16.62
  • Average True Range (ATR)
  • BDTX 0.23
  • IGI 0.18
  • MACD
  • BDTX 0.01
  • IGI -0.01
  • Stochastic Oscillator
  • BDTX 5.26
  • IGI 20.00

About BDTX Black Diamond Therapeutics Inc.

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

About IGI Western Asset Investment Grade Defined Opportunity Trust Inc.

Western Asset Invstm Grd Dfnd Opp Tr Inc operates as a non-diversified closed-end management investment company. Its primary investment objective is to provide current income and then liquidate & distribute substantially all of the Fund's net assets to stockholders. As a secondary investment objective, the Fund will seek capital appreciation. The Fund seeks to achieve its investment objectives by investing at least 80% of its net assets in investment-grade corporate fixed-income securities of varying maturities.

Share on Social Networks: